Bicycle Therapeutics Secures Long-Term Uranium Supply, Partners to Develop 212Pb Radiopharmaceuticals

Bicycle Therapeutics has established multiple strategic partnerships to support its wholly owned radiopharmaceutical pipeline. A 15-year contract with the UK Nuclear Decommissioning Authority provides access to up to 400 tonnes of reprocessed uranium, while a partnership with the UK National Nuclear Laboratory will scale up the extraction of 228Th for processing into a 212Pb generator. An agreement with SpectronRx will develop a bespoke 212Pb generator, with initial quantities successfully produced. The partnerships aim to create an end-to-end supply chain for Bicycle's radiopharmaceuticals.